Učitavanje...
Immunotherapy in hematologic malignancies
The management of hematologic malignancies has traditionally relied on chemotherapy regimens, many of which are still in use today. However, with advancements in the knowledge of tumour pathophysiology, therapies are continually evolving. Monoclonal antibodies against specific targets on tumour cell...
Spremljeno u:
| Izdano u: | Curr Oncol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Multimed Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7193997/ https://ncbi.nlm.nih.gov/pubmed/32368182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5117 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|